August 26, 2020
Siddhartha Ganguly, MD, director of the lymphoma and myeloma program, division of hematological malignancies and cellular therapeutics, has been named the A. Drue Jennings Professor in Medical Oncology.
“Dr. Ganguly has been an outstanding member of our hematologic malignancies team and has played an essential role in establishing the excellence of our clinical oncology program, particularly in regards to our treatment and research efforts in multiple myeloma. This professorship recognizes that role and enables him to further enhance our multiple myeloma clinical research efforts. This is vital as treatment paradigms rapidly evolve for this disease, given the many new agents that have been approved for myeloma in the last few years,” said Roy Jensen, MD, director of The University of Kansas Cancer Center.
The professorship is funded by the Hall Family Foundation and Sunderland Family Fund, and named after Drue Jennings, a longtime advocate of the cancer center. The gift will support the salary, travel and associated costs for the professorship, which will be at the cancer center and in the Department of Internal Medicine at the University of Kansas Medical Center. Professorships such as this are vital in helping the cancer center achieve the next step in our quest to conquer all cancers: Comprehensive Cancer Center designation.